Page 21 - பார்ட்லெட் பிராந்திய மருத்துவமனை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NIH devising study on rare allergic reactions to coronavirus vaccine Joel Achenbach Replay Video UP NEXT Officials at the National Institutes of Health are rushing to devise a study to find out why, in a few rare cases, people have had severe allergic reactions to the Pfizer coronavirus vaccine. The goal is to identify the component of the vaccine most likely to be responsible for these potentially life-threatening incidents, known as anaphylaxis. No cases have yet been associated with the other newly authorized vaccine, made by Moderna, but it is being administered to the general public for the first time this week and has similar components to the one developed by Pfizer and its partner BioNTech.

United statesUnited kingdomFranklin adkinsonPeter marksAnthonys fauciDaniel rotrosenCenters for diseaseDivision of allergyNational institute of allergyNational institutes of healthDrug administrationBiontechvaccine at regional medical centerDavid paul morris bloomberg healthJohns hopkins medical schoolWashington postNational institutes